Akita H, Chiba H, Tsuji M, Hui S P, Takahashi Y, Matsuno K, Kobayashi K
Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hum Genet. 1995 Nov;96(5):521-6. doi: 10.1007/BF00197405.
The effect of a polymorphism, guanine (G) to adenine (A) substitution in the promoter of apolipoprotein A-I gene at a position 78 bp upstream of the transcription initiation site, on the serum high-density lipoprotein (HDL)-cholesterol level was studied in 168 Japanese subjects with HDL-cholesterol levels ranging from 26 to 171 mg/dl. Considering the significant effect of cholesteryl ester transfer protein (CETP) on the HDL-cholesterol level and the common occurrence of its deficiency, we performed statistical analyses separately for two groups: one without CETP deficiency (n = 126) and the other with CETP deficiency (n = 42). In the group without CETP deficiency, in which the numbers of G/G, G/A, and A/A genotypes were 92 (73.0%), 28 (22.2%), and 6 (4.8%), respectively, the frequency of the A allele in the subjects with HDL-cholesterol levels of > or = 70 mg/dl did not differ from subjects with HDL-cholesterol levels of < or = 69 mg/dl, irrespective of gender: 0.154 and 0.145 in males, and 0.182 and 0.174 in females, respectively, for the > or = 70 mg/dl and < or = 69 mg/dl groups. Additionally, the HDL-cholesterol levels for the subjects with the G/G genotype did not differ from those for the subjects with the A allele: 64 +/- 22, 58 +/- 14, 77 +/- 14 and 62 +/- 16 mg/dl, respectively, for the G/G, G/A, A/A, and G/A + A/A in males, and 72 +/- 18, 74 +/- 24, 63 +/- 4, and 73 +/- 23 mg/dl in females. For the group with CETP deficiency, in which the numbers of G/G and G/A + A/A genotypes were 25 (59.5%) and 17 (40.5%), the HDL-cholesterol levels also did not differ: 98 +/- 24 mg/dl and 99 +/- 30 mg/dl, respectively, for the G/G and G/A + A/A genotypes. Thus, there is no evidence that the polymorphism has any effect on serum HDL-cholesterol levels regardless of CETP status. We conclude that the G-to-A substitution in the promoter of apolipoprotein A-I gene does not significantly alter serum HDL-cholesterol level.
在168名血清高密度脂蛋白(HDL)胆固醇水平在26至171mg/dl之间的日本受试者中,研究了位于转录起始位点上游78bp处的载脂蛋白A-I基因启动子中的一种多态性,即鸟嘌呤(G)到腺嘌呤(A)的替换对血清HDL胆固醇水平的影响。考虑到胆固醇酯转运蛋白(CETP)对HDL胆固醇水平有显著影响且其缺乏情况较为常见,我们将受试者分为两组分别进行统计分析:一组为无CETP缺乏者(n = 126),另一组为有CETP缺乏者(n = 42)。在无CETP缺乏的组中,G/G、G/A和A/A基因型的数量分别为92(73.0%)、28(22.2%)和6(4.8%),HDL胆固醇水平≥70mg/dl的受试者中A等位基因频率与HDL胆固醇水平≤69mg/dl的受试者相比无差异,无论性别如何:≥70mg/dl组和≤69mg/dl组男性分别为0.154和0.145,女性分别为0.182和0.174。此外,G/G基因型受试者的HDL胆固醇水平与携带A等位基因的受试者相比无差异:男性中G/G、G/A、A/A以及G/A + A/A基因型的HDL胆固醇水平分别为64±22、58±14、77±14和62±16mg/dl,女性分别为72±18、74±24、63±4和73±23mg/dl。对于有CETP缺乏的组,G/G和G/A + A/A基因型的数量分别为25(59.5%)和17(40.5%),其HDL胆固醇水平也无差异:G/G和G/A + A/A基因型分别为98±24mg/dl和99±30mg/dl。因此,无论CETP状态如何,均无证据表明该多态性对血清HDL胆固醇水平有任何影响。我们得出结论,载脂蛋白A-I基因启动子中的G到A替换不会显著改变血清HDL胆固醇水平。